INDO US BIOTECH
Back to Balance Sheet
|
INDO US BIOTECH Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹84 Cr | ₹69 Cr | ₹55 Cr | ₹43 Cr | ₹35 Cr |
What is the latest Total Liabilities ratio of INDO US BIOTECH ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹84 Cr |
Mar2023 | ₹69 Cr |
Mar2022 | ₹55 Cr |
Mar2021 | ₹43 Cr |
Mar2020 | ₹35 Cr |
How is Total Liabilities of INDO US BIOTECH Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹84 Cr | 21.65 | |
Mar2023 | ₹69 Cr | 24.88 | |
Mar2022 | ₹55 Cr | 27.04 | |
Mar2021 | ₹43 Cr | 25.13 | |
Mar2020 | ₹35 Cr | - |
Compare Total Liabilities of peers of INDO US BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDO US BIOTECH | ₹319.3 Cr | -5.9% | 0.7% | -26.9% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹12,773.5 Cr | -0.5% | -8.3% | -17.3% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,671.9 Cr | 3% | -4.1% | 1.6% | Stock Analytics | |
VENKYS (INDIA) | ₹1,971.1 Cr | -7.2% | -11.7% | -37.1% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,351.3 Cr | -2.5% | -7.2% | -32.8% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹540.8 Cr | 1.7% | -1.8% | NA | Stock Analytics |
INDO US BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDO US BIOTECH | -5.9% |
0.7% |
-26.9% |
SENSEX | -0% |
-2.4% |
1.2% |
You may also like the below Video Courses